News Sentiment

PIII sentiment intelligence

P3 Health Partners Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 55 Balanced news tone 60 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Care Facilities Read-through group
Latest close 9.80 Week of 10 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

74/100 classification confidence.

Company focus 60

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

-13.8% over one week, -19.9% over four weeks, trend active, and below fair value.

Latest direct headline Neutral

P3 Health Partners Company Profile & Introduction

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 74/100 classification
One-week reaction -13.8% Price reacting lower
Trend fit Trend active -19.9% over four weeks
Fair value -63.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 17
Neutral 37
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 60
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 20
Market source 4
TradingView 4
Moomoo 3
TradingKey 3
Sahm 3
GuruFocus.com 2
MarketBeat 2

Event Lens

What the news is about

Classified themes
Market update 24
Earnings 21
Guidance 7
Balance sheet 4
Analyst action 2
Regulatory and legal 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 60
Quantisnow Direct company coverage

P3 Health Partners Announces First Quarter 2026 Results

P3 Health Partners Inc. announced its First Quarter 2026 results. The announcement was made via a press release distributed by Quantisnow, a platform that provides real-time market data and news to retail investors. Quantisnow Plus members were alerted to this news shortly after

Tone
Neutral 50/100
Event
Earnings
Published
14 May 2026 21:40
Source
Quantisnow
Stock Titan Direct company coverage

P3 Health Partners (NASDAQ: PIII) lifts 2026 EBITDA guidance after Q1 turnaround

P3 Health Partners (NASDAQ: PIII) reported a significant financial turnaround in Q1 2026, achieving a net income of $3.0 million compared to a $44.2 million loss in the prior year, with Adjusted EBITDA reaching $25.8 million. This improvement led the company to raise its full-yea

Tone
Positive 72/100
Event
Guidance
Published
14 May 2026 20:09
Source
Stock Titan
Stock Titan Direct company coverage

From $44.2M loss to $3M profit: inside P3 Health’s Q1 shift

P3 Health Partners (NASDAQ: PIII) announced its Q1 2026 financial results, revealing a significant turnaround from a $44.2 million net loss in the prior year to a $3.0 million net income. This improvement is attributed to strategic contract restructuring, network concentration, a

Tone
Positive 67/100
Event
Earnings
Published
14 May 2026 20:09
Source
Stock Titan
Sahm Direct company coverage

Full Transcript: P3 Health Partners Q1 2026 Earnings Call

P3 Health Partners reported strong Q1 2026 results, exceeding internal expectations with $26 million in adjusted EBITDA, driven by contract restructuring, operational redesign, and improved payer economics. The company raised its full-year 2026 adjusted EBITDA outlook to $20 mill

Tone
Positive 72/100
Event
Earnings
Published
14 May 2026 09:10
Source
Sahm
Stock Titan Direct company coverage

Warrants, debt and pay on ballot at P3 Health Partners (NASDAQ: PIII) 2026 meeting

P3 Health Partners (PIII) will hold its 2026 virtual annual stockholder meeting on June 9, 2026. Key proposals include the election of three Class II directors, ratification of BDO USA, P.C. as auditor, an advisory vote on executive compensation, and a significant proposal to app

Tone
Negative 39/100
Event
Balance sheet
Published
30 Apr 2026 20:09
Source
Stock Titan
MSN Direct company coverage

P3 Health Partners (PIII) price target decreased by 12.50% to 3.57

P3 Health Partners (PIII) has seen its price target reduced by 12.50% to $3.57. This adjustment reflects a change in analyst expectations for the company's future stock performance. Investors will likely monitor further developments and analyst reports regarding PIII.

Tone
Negative 14/100
Event
Analyst action
Published
29 Apr 2026 13:39
Source
MSN
Stock Titan Direct company coverage

P3 Health Partners (NASDAQ: PIII) adds $70M preferred units and warrants

P3 Health Partners (NASDAQ: PIII) has undertaken a significant financial restructuring with its largest investor, Chicago Pacific Founders, to regain Nasdaq compliance. This involves exchanging $252.48 million of promissory note debt into various series of non-convertible preferr

Tone
Negative 39/100
Event
Balance sheet
Published
28 Apr 2026 21:10
Source
Stock Titan
Stock Titan Direct company coverage

P3 Health Partners (NASDAQ: PIII) asks shareholders to OK 3.34M warrant shares

P3 Health Partners Inc. (PIII) is seeking shareholder approval for the issuance of up to 3,341,130 shares of Class A common stock upon the exercise of warrants held by VBC Growth SPV 5, LLC. This approval is required under Nasdaq Listing Rule 5635(d) due to a May 2025 financing d

Tone
Neutral 50/100
Event
Regulatory and legal
Published
20 Apr 2026 20:09
Source
Stock Titan
Stock Titan Direct company coverage

P3 Health Partners (NASDAQ: PIII) deepens 2025 loss but guides to sharp EBITDA improvement in 2026

P3 Health Partners reported a deepened net loss in 2025 but projects a significant improvement in Adjusted EBITDA for 2026, aiming for a positive midpoint of $10 million, suggesting a $170 million year-over-year improvement. Despite a decline in at-risk membership and total reven

Tone
Neutral 50/100
Event
Market update
Published
26 Mar 2026 20:10
Source
Stock Titan